Stoke Therapeutics, Inc. short interest in 2021
In 2021, Stoke Therapeutics, Inc.'s disclosed short interest ran from 10.32% of shares outstanding on 15 Jan 2021 to 7.47% on 31 Dec 2021, a change of -2.85 percentage points. The year's high was 10.40% on 29 Jan 2021 and its low 3.79% on 30 Jul 2021, averaging 7.02% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.84 days on 26 Feb 2021. Full history: Stoke Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 10.32% (15 Jan 2021)
- End of year
- 7.47% (31 Dec 2021)
- Change
- -2.85 pp
- High
- 10.40% (29 Jan 2021)
- Low
- 3.79% (30 Jul 2021)
- Average
- 7.02%
- Highest days to cover
- 32.84 (26 Feb 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 10.32% | 26.05 | results (8-K) |
| 29 Jan 2021 | 10.40% | 30.11 | |
| 12 Feb 2021 | 10.06% | 31.55 | |
| 26 Feb 2021 | 9.85% | 32.84 | |
| 15 Mar 2021 | 7.79% | 15.75 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 8.62% | 13.70 | |
| 15 Apr 2021 | 8.60% | 19.64 | |
| 30 Apr 2021 | 8.16% | 13.18 | |
| 14 May 2021 | 8.37% | 18.59 | 10-Q filed, results (8-K) |
| 28 May 2021 | 7.39% | 21.28 | |
| 15 Jun 2021 | 6.63% | 18.14 | |
| 30 Jun 2021 | 6.34% | 9.22 | |
| 15 Jul 2021 | 5.59% | 15.65 | |
| 30 Jul 2021 | 3.79% | 14.33 | |
| 13 Aug 2021 | 3.96% | 10.31 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 4.22% | 19.72 | |
| 15 Sep 2021 | 4.19% | 18.55 | |
| 30 Sep 2021 | 5.38% | 10.71 | |
| 15 Oct 2021 | 5.11% | 16.52 | |
| 29 Oct 2021 | 5.50% | 21.51 | |
| 15 Nov 2021 | 6.70% | 13.00 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 6.64% | 11.96 | |
| 15 Dec 2021 | 7.34% | 9.77 | |
| 31 Dec 2021 | 7.47% | 11.74 |
See also: Stoke Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.